Dare Bioscience, Inc.
DARE· Nasdaq
DAREDare Bioscience, Inc.
Filed Mar 30, 2023 · 10-K · 89 days after period end · 0001401914-23-000013
derived · Computed from the longer spans the company filed.
| Metric | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures | Q4 2019dderived from reported figures |
|---|---|---|---|---|
| Net Income | -$15.94M | -$9.54M | -$8.44M | -$3.87M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Dare Bioscience, Inc. · CIK 1401914 · Engraved from SEC EDGAR
ended Dec 31, 2022 · filed Mar 30, 2023 · 89 d after period end
